CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-16 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,900 | $28.30 | $110K | 2,325 |
| 2016-12-16 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (right to buy) | −3,900 | 117,048 | ||
| 2016-12-08 | Wahlstrom Mats Director | Sale | −46,190 | $27.52 | $1.3M | 0 |
| 2016-12-07 | Wahlstrom Mats Director | Sale | −7,393 | $27.50 | $203K | 46,190 |
| 2016-12-01 | Herman Alan C. Chief Scientific Officer | Sale | −3,200 | $27.01 | $86K | 143,917 |
| 2016-12-01 | Herman Alan C. Chief Scientific Officer | Sale | −8,133 | $27.55 | $224K | 135,784 |
| 2016-11-18 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +3,900 | $13.50 | $53K | 6,225 |
| 2016-11-18 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,900 | $28.19 | $110K | 2,325 |
| 2016-11-18 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (right to buy) | −3,900 | 120,948 | ||
| 2016-11-01 | Herman Alan C. Chief Scientific Officer | Sale | −11,333 | $27.53 | $312K | 147,117 |
| 2016-10-21 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +3,900 | $13.50 | $53K | 6,225 |
| 2016-10-21 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,900 | $30.62 | $119K | 2,325 |
| 2016-10-21 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (right to buy) | −3,900 | 124,848 | ||
| 2016-10-03 | Herman Alan C. Chief Scientific Officer | Sale | −8,096 | $25.47 | $206K | 161,687 |
| 2016-10-03 | Herman Alan C. Chief Scientific Officer | Sale | −3,237 | $26.26 | $85K | 158,450 |
| 2016-09-26 | Viret Jean-Frederic Chief Financial Officer | Option exercise | +3,900 | $13.50 | $53K | 6,225 |
| 2016-09-26 | Viret Jean-Frederic Chief Financial Officer | Sale | −3,900 | $29.88 | $117K | 2,325 |
| 2016-09-26 | Viret Jean-Frederic Chief Financial Officer | Option exercise · Stock Option (right to buy) | −3,900 | 128,748 | ||
| 2016-09-21 | Lanfear Dennis M President and CEO | Sale | −50 | $31.75 | $2K | 1,337,566 |
| 2016-09-20 | Lanfear Dennis M President and CEO | Sale | −4,010 | $31.75 | $127K | 1,337,616 |
Page 26 of 39 · 768 trades